Brief: China Medical System Says Entered License, Collaboration & Distribution Agreement
Aug 12 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* THROUGH UNITS, ENTERED LICENSE, COLLABORATION AND
DISTRIBUTION
AGREEMENT WITH EYE TECH CARE
* AGREEMENT FOR EYEOP1 ULTRASOUND GLAUCOMA TREATMENT DEVICE
* MADE EQUITY INVESTMENT AND ACQUIRED APPROXIMATELY 33.4%
EQUITY
INTEREST IN EYE TECH CARE
* GROUP GAINED EXCLUSIVE LICENSE TO IMPORT, EXPORT EYEOP1 IN
CHINA, HK, MACAO, TAIWAN AND 11 SOUTHEAST ASIAN COUNTRIES
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says